10x Genomics与新加坡A*STAR基因组研究所启动TISHUMAP研究,推动AI驱动的药物靶点发现
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - PR Newswire
生物技术与制药领域的最新动态
10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery - PR Newswire
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - Pharmaceutical Technology
Danaher and Shanghai biotech company announce strategic partnership - China Daily
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT - Business Wire
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing - Business Wire
Waters to Merge with BD Biosciences in $17.5 Billion Life Sciences Deal - Chromatography Online
Enabling Rapid Genomic and Multiomic Data Analysis with Illumina DRAGEN™ v4.4 on Amazon EC2 F2 Instances - Amazon Web Services (AWS)
Cytiva boosts Asia footprint with bioprocessing push and local partnerships - koreabiomed.com
A Big Move By Waters Corporation And Becton, Dickinson And Company (NYSE:WAT) - Seeking Alpha
Why Waters Corporation (WAT) Stock Is Down Today - Yahoo Finance
Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call - Yahoo Finance
10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 - Yahoo Finance
What is genomic AI? - Illumina
"In-Region, For Region": Cytiva Builds Out $1.6B in Global Expansion Projects - GEN - Genetic Engineering and Biotechnology News
Illumina to Acquire SomaLogic for $350 Million, Expanding into Proteomics and Precision Medicine - Yahoo Finance
Winners And Losers Of Q1: Waters Corporation (NYSE:WAT) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Lonza leaders on manufacturing readiness: Meeting the cell and gene therapy challenge - BioSpectrum Asia
Emmanuel Ligner - The Medicine Maker
Cellular Origines partners with Johnson & Johnson - European Biotechnology Magazine
Illumina picks up proteomics developer SomaLogic from Standard BioTools for $425M - Fierce Biotech